Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hon Pui

Showing results (461-470 of 611) with videos related to

Pageof 62
Sort By:
Hepatology (Baltimore, Md.)|July 18, 2018
Serum Alanine Aminotransferase Elevations in Survivors of Childhood Cancer: A Report From the St. Jude Lifetime Cohort StudyDaniel M Green, Mingjuan Wang, Matthew J Krasin, et al.
Pediatric Blood & Cancer|May 12, 2018
Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort StudyIsrael Fernandez-Pineda, Andrew M Davidoff, Lu Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort studyWassim Chemaitilly, Zhenghong Li, Sujuan Huang, et al.
The Lancet. Oncology|March 15, 2020
Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation studySeth E Karol, Thomas B Alexander, Amit Budhraja, et al.
Journal of the National Cancer Institute|September 4, 2020
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in ChildrenShawn H R Lee, Maoxiang Qian, Wentao Yang, et al.
Leukemia|March 14, 2021
Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networksJonathan D Diedrich, Qian Dong, Daniel C Ferguson, et al.
Blood|July 1, 2004
Gene expression profiling of pediatric acute myelogenous leukemiaMary E Ross, Rami Mahfouz, Mihaela Onciu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemiaKjeld Schmiegelow, Mette Frandsen Levinsen, Andishe Attarbaschi, et al.
The New England Journal of Medicine|April 13, 2012
Outcomes after induction failure in childhood acute lymphoblastic leukemiaMartin Schrappe, Stephen P Hunger, Ching-Hon Pui, et al.
The Lancet. Oncology|May 11, 2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialJeffrey E Rubnitz, Hiroto Inaba, Gary Dahl, et al.
Pageof 62

Showing results (461-470 of 611) with videos related to

Sort By:
Pageof 62
Hepatology (Baltimore, Md.)|July 18, 2018
Serum Alanine Aminotransferase Elevations in Survivors of Childhood Cancer: A Report From the St. Jude Lifetime Cohort StudyDaniel M Green, Mingjuan Wang, Matthew J Krasin, et al.
Pediatric Blood & Cancer|May 12, 2018
Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort StudyIsrael Fernandez-Pineda, Andrew M Davidoff, Lu Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort studyWassim Chemaitilly, Zhenghong Li, Sujuan Huang, et al.
The Lancet. Oncology|March 15, 2020
Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation studySeth E Karol, Thomas B Alexander, Amit Budhraja, et al.
Journal of the National Cancer Institute|September 4, 2020
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in ChildrenShawn H R Lee, Maoxiang Qian, Wentao Yang, et al.
Leukemia|March 14, 2021
Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networksJonathan D Diedrich, Qian Dong, Daniel C Ferguson, et al.
Blood|July 1, 2004
Gene expression profiling of pediatric acute myelogenous leukemiaMary E Ross, Rami Mahfouz, Mihaela Onciu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemiaKjeld Schmiegelow, Mette Frandsen Levinsen, Andishe Attarbaschi, et al.
The New England Journal of Medicine|April 13, 2012
Outcomes after induction failure in childhood acute lymphoblastic leukemiaMartin Schrappe, Stephen P Hunger, Ching-Hon Pui, et al.
The Lancet. Oncology|May 11, 2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialJeffrey E Rubnitz, Hiroto Inaba, Gary Dahl, et al.
Pageof 62